Detection of circulating tumor DNA following neoadjuvant chemotherapy and surgery to anticipate early relapse in ER positive and HER2 negative breast cancer: Analysis from the PENELOPE-B trial
ASCO 2023
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients